Publications
- Incidence of adverse events after loading phase of the brolucizumab therapy of neovascular AMD: Real-life evidence in the Czech Republic2023 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, Central Library of Charles University, First Faculty of Medicine
- Effect of baseline central retinal thickness on the results of treatment of diabetic macular edema with aflibercept: real-life evidence in the Czech republic2022 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Intravitreal ranibizumab in pregnant patient with myopic choroidal neovascular membrane. A case report2022 | Third Faculty of Medicine
- Two-year results of a combined regimen of aflibercept treatment in three types of choroidal neovascular membrane in the wet form of age-related macular degeneration: Real-life evidence in the Czech Republic2021 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Long-term Results of a Combined Procedure of Cataract Surgery and Descemet Membrane Endothelial Keratoplasty With Stromal Rim2021 | Third Faculty of Medicine
- Asymmetric response to ranibizumab in mixed choroidal neovascularization in a neovascular age-related macular degeneration diagnosed on OCT angiography - case report2021 | Third Faculty of Medicine
- Uveal effusion syndrome. Case report2021 | Third Faculty of Medicine
- Response to Aflibercept Therapy in Three Types of Choroidal Neovascular Membrane in Neovascular Age-Related Macular Degeneration: Real-Life Evidence in the Czech Republic2019 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- One-year follow-up outcomes of the treatment of wet age-related macular degeneration with aflibercept2018 | Third Faculty of Medicine
- Biosimilar SB11 versus reference ranibizumab in neovascular age-related macular degeneration: 1-year phase III randomised clinical trial outcomes2023 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, Central Library of Charles University
Loading network view...
